Global Intracranial Aneurysm Market Insights Forecasts to 2033

• The Global Intracranial Aneurysm Market Size was Valued at USD 1.46 Billion in 2023
• The Market Size is Growing at a CAGR of 7.32% from 2023 to 2033
• The Worldwide Intracranial Aneurysm Market Size is Expected to Reach USD 2.96 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Intracranial Aneurysm Market Size is Anticipated to Exceed USD 2.96 Billion by 2033, Growing at a CAGR of 7.32% from 2023 to 2033.

Market Overview

A cerebral or intracranial aneurysm is an atypical localized dilatation of an artery in the brain caused by a blood vessel wall's inner muscle layer (the intima). A subarachnoid hemorrhage (SAH), which causes bleeding into the area around the brain, is caused by a "blister-like" dilatation in the artery that can suddenly narrow and burst. Hemorrhage of this type can result in a coma, stroke, and even death. Aneurysms can range in size from less than 1/8 of an inch to about one inch. Giant aneurysms are aneurysms that are greater than one inch, very risky, and challenging to treat. It is uncertain exactly how cerebral aneurysms form, expand, and burst. The two forms of aneurysms that are most commonly found are berry and saccular. These aneurysm types affect about 90% of all aneurysm cases. According to a global study on the intracranial aneurysm market, the rising number of cases of brain aneurysms entail the bulging of an artery in the brain. Widening, ballooning, and swelling are the results. Aneurysms impair nerve function by weakening the walls of the blood vessels. The increased number of elderly people is thought to be the primary cause of cerebral aneurysms and their rising incidence, which is driving the development of intracranial aneurysm treatments. Because weak walls are often thin and have little effect on the support that these layers give, there is a growing need for intracranial aneurysm treatments and remedies. The innovative, cutting-edge technology combined with intracranial aneurysm treatment and solutions is responsible for the growing intracranial aneurysm market size. End-user patients and treatment facilities utilize intracranial aneurysm therapy and solution techniques when the chance of wall rupture rises. The need for intracranial aneurysm treatment solutions is fuelled by the following methods of treating brain aneurysms: medicinal therapy, surgical clipping or endovascular therapy, or coiling alone or with auxiliary devices.

Report Coverage

This research report categorizes the market for the global intracranial aneurysm market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global intracranial aneurysm market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global intracranial aneurysm market.

Driving Factors

The need for intracranial aneurysm treatment and solutions is being driven by an increase in high blood pressure patients as a result of blood vessel and trauma injuries as well as hypertension that results in cases of intracranial brain aneurysms. The intracranial aneurysm market report states that the market is dynamic and operates on all levels. Many people are currently at risk of developing a brain aneurysm. The senior population is more susceptible to the illness, is more afflicted by it, and is looking for quick cures. The government is concentrating more and more on treating cerebral aneurysms as the number of cases rises, offering everything from medication to consultation. The need for intracranial aneurysm treatment options is being fueled by the relief that less invasive operations are providing for patients. Intracranial aneurysms are being treated using cutting-edge technology and novel methods such as endovascular coiling, which are part of minimally invasive procedures that are highly recommended by medical professionals. During this surgery, an artery with an aneurysm is used to implant a microcatheter into the groin region. This keeps the blood from getting to other areas of the brain and monitors the aneurysm's health. This drives up the price of treatments for cerebral aneurysms.

Restraining Factors

The main barriers to the market's growth include the high cost of illness management and problems following craniotomy surgery. The outbreak's plague also had a negative impact on the intracranial aneurysm market because research and development centers particularly those that study the benefits of minimally invasive surgeries were idle and healthcare facilities were overflowing with COVID-19 patients.

Market Segmentation

The global intracranial aneurysm market share is classified into type and end user.

• The endovascular coiling segment is expected to hold the largest share of the global intracranial aneurysm market during the forecast period.   

Based on the type, the global intracranial aneurysm market is divided into surgical clipping, endovascular coiling, flow diverters, and others. Among these, the endovascular coiling segment is expected to hold the largest share of the global intracranial aneurysm market during the forecast period. The endovascular coiling technique is a minimally invasive method for diagnosing and treating brain aneurysms using a catheter. Using this technique, a catheter is inserted into the artery that supplies the aneurysm from the groin area. After positioning, embolic coils or liquids are inserted through the catheter to cause embolization, which stops blood flow to the aneurysm. The leading players in the industry are driving the growth of this market with their advances in neurological disease treatment products.

• The hospital segment is expected to hold the largest share of the global intracranial aneurysm market during the forecast period.   

Based on the end user, the global intracranial aneurysm market is divided into hospitals, clinics, and others. Among these, the hospital segment is expected to hold the largest share of the global intracranial aneurysm market during the forecast period. This is linked to the utilization of cutting-edge medical technology in operating rooms and critical care units, the growth in the number of hospitals around the globe, and an increase in government financing for healthcare facilities. To improve patient care, hospitals are using a lot of technologically sophisticated equipment. These devices are not only simplifying treatment procedures but are also helping provide better, faster, and more accurate results.

Regional Segment Analysis of the global intracranial aneurysm market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global intracranial aneurysm market over the predicted timeframe.

North America is anticipated to hold the largest share of the global intracranial aneurysm market over the predicted timeframe. The high prevalence of hypertension and stroke, the aging population, and the existence of a well-established healthcare system. Furthermore, the rise in the demand for minimally invasive operations and the rising incidence of cerebral aneurysms are propelling the market expansion in this area. Furthermore, a number of efforts being undertaken by various organizations are anticipated to accelerate market expansion. The Bee Foundation (TBF), for instance, is a non-profit organization whose mission is to advance awareness and reduce the death rates related to brain aneurysms via innovative research.

Asia Pacific is expected to grow at the fastest pace in the global intracranial aneurysm market during the forecast period. The growing aging population, high levels of stress in daily life, an increase in the prevalence of hypertension, advances in diagnostic quality, and increased patient affordability are some of the variables that are blamed for this. In Asia Pacific, these variables have combined to produce a sizable number of cerebral aneurysm surgeries. Regional market growth may also be aided by the possibility of expansion into developing nations like China, India, and Brazil. One factor that is expected to drive market expansion is the increasing trend of medical tourism in India, where expenses for intracranial procedures are cheaper than in industrialized countries like the United States.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global intracranial aneurysm market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic plc
• Stryker Corporation
• MicroPort Scientific Corporation.
• Johnson & Johnson Services, Inc.
• MicroVention Inc.
• B. Braun Melsungen AG
• Integra Life Sciences
• RAUMEDIC AG
• Terumo Corporation
• Delta Surgical
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2023, Cerus Endovascular Ltd., a manufacturer of neuro-interventional devices for the treatment of intracranial aneurysms, was purchased by Stryker Corporation. Stryker hopes to increase the range of products it offers for treating aneurysms with this purchase.
• In June 2022, the Indian subsidiary of Medtronic plc launched a pipeline vantage embolization device in India for the treatment of brain aneurysms.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global intracranial aneurysm market based on the below-mentioned segments: 

Global Intracranial Aneurysm Market, By Type

• Surgical Clipping
• Endovascular Coiling
• Flow Diverters
• Others

Global Intracranial Aneurysm Market, By End User

• Hospitals
• Clinics
• Others

Global Intracranial Aneurysm Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa